Pharmaceutical Executive
February 01, 2010
Issue PDF
0
0
Shire’s Second Act
February 01, 2010
Features
0
0
As Genentech's Avastin continues to mature and spread its branches, the company is looking for high profits on the back end.
February 01, 2010
Columns
0
0
Improving field force business planning requires managers to run each sales territory as if it is a self-contained business operation.
February 01, 2010
Washington Report
0
0
R&D is surging, but new methods and data raise new manufacturing and regulatory challenges.
February 01, 2010
Features
0
0
Sales compensation practices are due for an overhaul in 2010.
February 01, 2010
From the Editor
0
0
Innovation won't happen until the industry is ready to sit down and make a big change.